MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...

Investing.com -- Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) stock rose 2% following positive interim results from two Phase 2 clinical trials of its ARCT-810 mRNA therapeutic for ornithine ...

Carnival remains a leader in the cruise industry, with eight global brands and more than 90 ships delivering holiday experiences. The global cruise market is still underpenetrated, offering cruise ...

Shareholder distributions are fair. Starting in 2023, management decreased expected dividend growth to 2.5% from 5% because of the additional investments needed to strengthen energy security. Since ...

Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) edged up 2% after the company shared encouraging interim results ...

Parkinson’s disease, the second most common neurodegenerative disorder globally, is often associated with vocal impairments, ...

The data were presented at the MaculArt Meeting, June 29 – July 1, 2025 in Paris. MGB represents a potential alternative to current standard of care ... MGB provides a unique mechanism of action of ...

Reliable execution claims refer to average slippage rates on pending orders based on data collected between 2024-09-06 to 2024-09-12, 2025-01-24 to 2025-01-29 and 2025-05-27 to 2025-05-29 for gold on ...

Syria and Israel have been holding discussions for weeks about normalization, officials say.

Philip Morris International Inc. rated Hold with $170 target: strong smoke-free growth & margins vs. peers. Click for PM ...

The National Oceanic and Atmospheric Administration said Monday it is delaying by one month the planned cutoff of satellite ...